Randy A Albrecht | Mount Sinai

Biography

Research Topics

Antivirals, Autophagy, Biodefense, Cellular Immunity, Comparative Anatomy, Coronavirus, Cytokines, Epithelial Cells, Immune Antagonism, Immunology, Infectious Disease, Influenza Virus, Interferon Antagonists, Lung, Molecular Biology, Mucosal Immunology, Paramyxovirus, SARS Virus, Vaccine Development, Viruses and Virology

Education

PhD, Louisiana State University Health Sciences Center Shreveport

Publications

130

Publications

Selected Publications

System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans. Mario Cortese, Thomas Hagan, Nadine Rouphael, Sheng Yang Wu, Xia Xie, Dmitri Kazmin, Florian Wimmers, Shakti Gupta, Robbert van der Most, Margherita Coccia, Prabhu S. Aranuchalam, Helder I. Nakaya, Yating Wang, Elizabeth Coyle, Shu Horiuchi, Hanchih Wu, Mary Bower, Aneesh Mehta, Clifford Gunthel, Steve E. Bosinger, Yuri Kotliarov, Foo Cheung, Pamela L. Schwartzberg, Ronald N. Germain, John Tsang, Shuzhao Li, Randy Albrecht, Hideki Ueno, Shankar Subramaniam, Mark J. Mulligan, Surender Khurana, Hana Golding, Bali Pulendran. Nature Immunology

Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity. Raveen Rathnasinghe, Lauren A. Chang, Rebecca Pearl, Sonia Jangra, Amy Aspelund, Alaura Hoag, Soner Yildiz, Ignacio Mena, Weina Sun, Madhumathi Loganathan, Nicholas Alexander Crossland, Hans P. Gertje, Anna Elise Tseng, Sadaf Aslam, Randy A. Albrecht, Peter Palese, Florian Krammer, Michael Schotsaert, Thomas Muster, Adolfo García-Sastre. npj Vaccines

Seven Opportunities for Effective Biosafety and Biosecurity Governance. David R. Gillum, Antony Schwartz, Randy A. Albrecht, Rebecca L. Moritz. Health security

View All Publications

Office Locations

Annenberg Building Floor 16 Room 16-94A

1468 Madison Ave

New York, NY 10029

212-241-8255

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Albrecht during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Editorial Services

BRANY

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Albrecht during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Editorial Services

BRANY

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.